InvestorsHub Logo
Followers 14
Posts 187
Boards Moderated 0
Alias Born 10/29/2022

Re: CaptBeer post# 424043

Thursday, 05/09/2024 5:37:10 AM

Thursday, May 09, 2024 5:37:10 AM

Post# of 427500
Captain,

Thank you for keeping us abreast on PREPARE RCT (PRevention Using EPA Against coloREctal).

As a reminder, Amarin’s Form 10-K 2022 for the year ending December 31, 2021 asserts that the Company "owns" "one additional patent related to the use of VASCEPA to treat prostate cancer with a term that expires in 2037."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News